Albert E. Schmelzer

863 total citations
20 papers, 603 citations indexed

About

Albert E. Schmelzer is a scholar working on Molecular Biology, Genetics and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Albert E. Schmelzer has authored 20 papers receiving a total of 603 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 6 papers in Genetics and 4 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Albert E. Schmelzer's work include Viral Infectious Diseases and Gene Expression in Insects (15 papers), Protein purification and stability (7 papers) and Virus-based gene therapy research (6 papers). Albert E. Schmelzer is often cited by papers focused on Viral Infectious Diseases and Gene Expression in Insects (15 papers), Protein purification and stability (7 papers) and Virus-based gene therapy research (6 papers). Albert E. Schmelzer collaborates with scholars based in United States, United Kingdom and Poland. Albert E. Schmelzer's co-authors include William M. Miller, James A. Zanghi, Richard H. Knop, Varnika Roy, Michael C. Jewett, Natalia I. Majewska, Thomas Linke, Yuyan Chen, Liyan Chen and Dengfeng Liu and has published in prestigious journals such as Scientific Reports, Journal of Medicinal Chemistry and Journal of Chromatography A.

In The Last Decade

Albert E. Schmelzer

20 papers receiving 582 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Albert E. Schmelzer United States	13	495	150	146	73	51	20	603
Inn H. Yuk United States	16	788 1.6×	114 0.8×	280 1.9×	132 1.8×	27 0.5×	30	875
Martin Gawlitzek France	11	728 1.5×	95 0.6×	297 2.0×	71 1.0×	14 0.3×	18	791
N. Huzel Canada	15	575 1.2×	86 0.6×	108 0.7×	75 1.0×	27 0.5×	21	663
Heino Büntemeyer Germany	14	385 0.8×	79 0.5×	63 0.4×	102 1.4×	24 0.5×	32	508
Christopher C. Frye United States	11	638 1.3×	156 1.0×	162 1.1×	54 0.7×	19 0.4×	19	685
Marcos Oggero Argentina	12	302 0.6×	37 0.2×	161 1.1×	43 0.6×	12 0.2×	39	437
Guillermo I. Tous United States	11	408 0.8×	36 0.2×	158 1.1×	52 0.7×	57 1.1×	16	605
Elisabeth M. A. Curling United Kingdom	6	474 1.0×	101 0.7×	149 1.0×	45 0.6×	21 0.4×	9	525
Xiaojuan Yu China	11	275 0.6×	67 0.4×	84 0.6×	25 0.3×	69 1.4×	24	394

Countries citing papers authored by Albert E. Schmelzer

Since Specialization

Citations

This map shows the geographic impact of Albert E. Schmelzer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Albert E. Schmelzer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Albert E. Schmelzer more than expected).

Fields of papers citing papers by Albert E. Schmelzer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Albert E. Schmelzer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Albert E. Schmelzer. The network helps show where Albert E. Schmelzer may publish in the future.

Co-authorship network of co-authors of Albert E. Schmelzer

This figure shows the co-authorship network connecting the top 25 collaborators of Albert E. Schmelzer. A scholar is included among the top collaborators of Albert E. Schmelzer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Albert E. Schmelzer. Albert E. Schmelzer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

Parupudi, Arun, Tomasz M. Witkos, Nicholas J. Bond, et al.. (2024). Size-exclusion chromatography as a multi-attribute method for process and product characterization of adeno-associated virus. Molecular Therapy — Methods & Clinical Development. 32(4). 101382–101382. 3 indexed citations

2.

Nagy, Abdou, et al.. (2023). Engineered CHO cells as a novel AAV production platform for gene therapy delivery. Scientific Reports. 13(1). 19210–19210. 8 indexed citations

3.

Linke, Thomas, et al.. (2023). Process economics evaluation and optimization of adeno‐associated virus downstream processing. Biotechnology and Bioengineering. 121(8). 2435–2448. 17 indexed citations

4.

Handlogten, Michael W., Jie Zhu, Lina Li, et al.. (2023). Accelerated cell culture process development and characterization for cilgavimab/tixagevimab (AZD7442) for the prevention and treatment of COVID‐19. Biotechnology and Bioengineering. 122(9). 2308–2318. 3 indexed citations

5.

Park, Andrew, Rebecca Halpin, Andrey Tovchigrechko, et al.. (2020). Chemically Defined, High-Density Insect Cell-Based Expression System for Scalable AAV Vector Production. Molecular Therapy — Methods & Clinical Development. 19. 330–340. 31 indexed citations

6.

Wang, Chunlei, Yuyan Chen, Xiaohui Zhao, et al.. (2019). Developing an Anion Exchange Chromatography Assay for Determining Empty and Full Capsid Contents in AAV6.2. Molecular Therapy — Methods & Clinical Development. 15. 257–263. 85 indexed citations

7.

Luo, Haibin, Xiangyang Wang, Yuling Li, et al.. (2017). Liquid-liquid phase separation causes high turbidity and pressure during low pH elution process in Protein A chromatography. Journal of Chromatography A. 1488. 57–67. 18 indexed citations

8.

Schmelzer, Albert E., et al.. (2017). A novel cholesterol/lipid delivery system for murine myeloma cell lines. Biotechnology Progress. 33(3). 795–803. 5 indexed citations

9.

Heffner, Kelley, et al.. (2017). Production and characterization of active recombinant human factor II with consistent sialylation. Biotechnology and Bioengineering. 114(9). 1991–2000. 7 indexed citations

10.

Roy, Varnika, et al.. (2017). A bicistronic vector with destabilized mRNA secondary structure yields scalable higher titer expression of human neurturin in E. coli. Biotechnology and Bioengineering. 114(8). 1753–1761. 8 indexed citations

11.

Majewska, Natalia I., et al.. (2017). Development of a CHO-Based Cell-Free Platform for Synthesis of Active Monoclonal Antibodies. ACS Synthetic Biology. 6(7). 1370–1379. 81 indexed citations

12.

Schmelzer, Albert E., et al.. (2002). Characterization of hybridoma cell responses to elevated pCO₂ and osmolality: Intracellular pH, cell size, apoptosis, and metabolism. Biotechnology and Bioengineering. 77(4). 369–380. 73 indexed citations

13.

Schmelzer, Albert E. & William M. Miller. (2002). Effects of osmoprotectant compounds on NCAM polysialylation under hyperosmotic stress and elevated pCO₂. Biotechnology and Bioengineering. 77(4). 359–368. 21 indexed citations

14.

Schmelzer, Albert E. & William M. Miller. (2002). Hyperosmotic Stress and Elevated pCO ₂ Alter Monoclonal Antibody Charge Distribution and Monosaccharide Content. Biotechnology Progress. 18(2). 346–353. 44 indexed citations

15.

Schmelzer, Albert E., et al.. (2002). Selected amino acids protect hybridoma and CHO cells from elevated carbon dioxide and osmolality. Biotechnology and Bioengineering. 78(7). 741–752. 43 indexed citations

16.

Schmelzer, Albert E., et al.. (2000). Considerations for osmolality measurement under elevatedpCO2: Comparison of vapor pressure and freezing point osmometry. Biotechnology and Bioengineering. 67(2). 189–196. 22 indexed citations

17.

Zanghi, James A., et al.. (1999). Bicarbonate concentration and osmolality are key determinants in the inhibition of CHO cell polysialylation under elevated pCO2 or pH. Biotechnology and Bioengineering. 65(2). 182–191. 52 indexed citations

18.

Zanghi, James A., et al.. (1999). Bicarbonate concentration and osmolality are key determinants in the inhibition of CHO cell polysialylation under elevated pCO2 or pH. Biotechnology and Bioengineering. 65(2). 182–182. 1 indexed citations

19.

Zanghi, James A., et al.. (1998). Role of Nucleotide Sugar Pools in the Inhibition of NCAM Polysialylation by Ammonia. Biotechnology Progress. 14(6). 834–844. 27 indexed citations

20.

Hagen, Timothy J., Steven W. Kramer, Kam F. Fok, et al.. (1998). 2-Iminopyrrolidines as Potent and Selective Inhibitors of Human Inducible Nitric Oxide Synthase. Journal of Medicinal Chemistry. 41(19). 3675–3683. 54 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact